Health and Healthcare

Puma Biotechnology : PBYI

All Puma Biotechnology Articles

49 Articles

Chris Lange | May 29, 2016 at 10:15 AM EDT

Key Movers to Look for Ahead of ASCO

The American Society of Clinical Oncology (ASCO) is gearing up for its annual meeting. At this meeting, cancer drug developers…

Chris Lange | May 25, 2016 at 9:40 AM EDT

5 Major Clinical Trial Results Coming Up

24/7 Wall St. has collected several big FDA decisions and imminent clinical trial results that should be coming up in…

Paul Ausick | Mar 29, 2016 at 4:04 PM EDT

The 52-Week Low Club for Tuesday

March 29, 2016: Here are four stocks trading with relatively heavy volume among 36 equities making new 52-week lows in…

Chris Lange | Mar 29, 2016 at 9:35 AM EDT

8 Major Biopharma Events Coming Later in 2016 and in 2017

FDA rulings can make or break some companies. 24/7 Wall St. has collected eight key FDA decisions coming up in…

Chris Lange | Mar 16, 2016 at 12:50 PM EDT

4 More Key FDA Decisions in March

24/7 Wall St. has collected a few more U.S. Food and Drug Administration (FDA) decisions coming up in March.

Chris Lange | Jan 2, 2016 at 10:15 AM EST

4 Top FDA Decisions Expected in Q1

24/7 Wall St. has collected four companies big FDA decisions coming up in the first quarter of 2016 and added…

Jon C. Ogg | Dec 20, 2015 at 10:15 AM EST

14 Fresh Analyst Stocks Called to Rise 50% to 100%

These 50% to 100% implied upside picks from analysts are generally coming with far more risk than traditional Dow stocks,…

Jon C. Ogg | Dec 14, 2015 at 8:40 AM EST

Top Analyst Upgrades and Downgrades: Coach, DuPont, GoPro, Match, Puma Bio, Square, Tesla and Many More

Monday’s top analyst upgrades, downgrades and initiations includes Coach, DuPont, GoPro, Match, Puma Biotechnology, Square and Tesla Motors.

Chris Lange | Nov 14, 2015 at 9:20 AM EST

7 BioHealth Movers That Cannot Be Ignored

The biotech companies 24/7 Wall St. has picked stood out from the rest with incredible gains or losses over the…

Jon C. Ogg | Aug 27, 2015 at 8:45 AM EDT

Top Analyst Upgrades and Downgrades: Amazon, Monsanto, Schlumberger, SolarCity, Western Digital, Yelp, Abercrombie and Many More

Thursday's top analyst upgrades, downgrades and initiations include Amazon.com, Monsanto, Schlumberger, SolarCity, Western Digital, Yelp, Abercrombie & Fitch.

Lee Jackson | May 12, 2015 at 8:20 AM EDT

4 Biotech Stocks Could Have Big Upside Before Russell Index Changes

Credit Suisse expects that biotech stocks will see the most promotions in the coming rebalance of the Russell Indexes.

Paul Ausick | Dec 18, 2014 at 12:00 PM EST

9 Big Stocks That Doubled in 2014

Here is a look at the top performers for 2014, nine stocks that have doubled and have a current market…

Jon C. Ogg | Jul 23, 2014 at 11:45 AM EDT

Is Puma Biotech For Real, Again?

Puma Biotechnology has just defied all odds in biotech. The stock has risen more than 200% in a single day,…

Lee Jackson | Jul 8, 2014 at 10:15 AM EDT

Upcoming Catalysts Could Drive Seven Biotech and Health Care Stocks Higher

ThinkstockBinary events are often the key element in moving a biotech or health care stock higher. Negative binary results or…

Jon C. Ogg | Apr 23, 2014 at 8:50 AM EDT

UBS Top Stocks to Buy Working for Cancer Cures

In a new research report, the Healthcare team at UBS took an in-depth look at the top companies that are…

1 2 3 4

Puma Biotechnology : PBYI

All Puma Biotechnology Articles

Key Movers to Look for Ahead of ASCO

5 Major Clinical Trial Results Coming Up

The 52-Week Low Club for Tuesday

8 Major Biopharma Events Coming Later in 2016 and in 2017

4 More Key FDA Decisions in March

4 Top FDA Decisions Expected in Q1

14 Fresh Analyst Stocks Called to Rise 50% to 100%

Top Analyst Upgrades and Downgrades: Coach, DuPont, GoPro, Match, Puma Bio, Square, Tesla and Many More

7 BioHealth Movers That Cannot Be Ignored

Top Analyst Upgrades and Downgrades: Amazon, Monsanto, Schlumberger, SolarCity, Western Digital, Yelp, Abercrombie and Many More

4 Biotech Stocks Could Have Big Upside Before Russell Index Changes

9 Big Stocks That Doubled in 2014

Is Puma Biotech For Real, Again?

Upcoming Catalysts Could Drive Seven Biotech and Health Care Stocks Higher

UBS Top Stocks to Buy Working for Cancer Cures

‘You’re Gonna Go Into Retirement Broke and Wait on Mom to Die’: Dave Ramsey’s Reality Check for a Caller Eyeing His Inheritance

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

EEM’s 0.69% Fee Quietly Costs You $690 a Year, but Your Cheaper Alternative Charges $90

'You're Gonna Go Into Retirement Broke and Wait on Mom to Die': Dave Ramsey's Reality Check for a Caller Eyeing His Inheritance

"You Don't Want to Pass the Burden of Investments Down to Your Daughter": Suze Orman's Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

‘You’re Gonna Go Into Retirement Broke and Wait on Mom to Die’: Dave Ramsey’s Reality Check for a Caller Eyeing His Inheritance

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

Puma Biotechnology : PBYI

All Puma Biotechnology Articles

Key Movers to Look for Ahead of ASCO

5 Major Clinical Trial Results Coming Up

The 52-Week Low Club for Tuesday

8 Major Biopharma Events Coming Later in 2016 and in 2017

4 More Key FDA Decisions in March

4 Top FDA Decisions Expected in Q1

14 Fresh Analyst Stocks Called to Rise 50% to 100%

Top Analyst Upgrades and Downgrades: Coach, DuPont, GoPro, Match, Puma Bio, Square, Tesla and Many More

7 BioHealth Movers That Cannot Be Ignored

Top Analyst Upgrades and Downgrades: Amazon, Monsanto, Schlumberger, SolarCity, Western Digital, Yelp, Abercrombie and Many More

4 Biotech Stocks Could Have Big Upside Before Russell Index Changes

9 Big Stocks That Doubled in 2014

Is Puma Biotech For Real, Again?

Upcoming Catalysts Could Drive Seven Biotech and Health Care Stocks Higher

UBS Top Stocks to Buy Working for Cancer Cures

‘You’re Gonna Go Into Retirement Broke and Wait on Mom to Die’: Dave Ramsey’s Reality Check for a Caller Eyeing His Inheritance

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

EEM’s 0.69% Fee Quietly Costs You $690 a Year, but Your Cheaper Alternative Charges $90

Featured Reads

'You're Gonna Go Into Retirement Broke and Wait on Mom to Die': Dave Ramsey's Reality Check for a Caller Eyeing His Inheritance

"You Don't Want to Pass the Burden of Investments Down to Your Daughter": Suze Orman's Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings